ADGMbenzinga

Adagio Medical Announces Progress in Ventricular Tachycardia Solutions, FULCRUM-VT Trial Over 40% Enrolled; Participation In 2025 European Heart Rhythm Association Meeting; CFO John Dahldorf To Leave March 2025, Transitional CFO John Dahldorf Appointed

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on March 17, 2025 by benzinga

    Adagio Medical Announces Progress in Ventricular Tachycardia Solutions, FULCRUM-VT Trial Over 40% Enrolled; Participation In 2025 European Heart Rhythm Association Meeting; CFO John Dahldorf To Leave March 2025, Transitional CFO John Dahldorf Appointed | ADGM Stock News | Candlesense